Birzeit Pharmaceutical Co (XPAE:BPC) Institutional Ownership: 0.32% (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAE:BPC Birzeit Pharmaceutical Co XPAE:BPC
87 GF Score
Price $3.66
GF Value $4.59
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Birzeit Pharmaceutical Co Institutional Ownership?

Birzeit Pharmaceutical Co XPAE:BPC +0.27% 87 Institutional Ownership is 0.32% as of Jul. 24, 2026. GuruFocus rates XPAE:BPC with a GF Score™ of 87/100 and a GF Value™ of $4.59 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Birzeit Pharmaceutical Co's institutional ownership is 0.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Birzeit Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Birzeit Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Birzeit Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Birzeit Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Birzeit Pharmaceutical Co Institutional Ownership Chart

Birzeit Pharmaceutical Co Historical Data

The historical data trend for Birzeit Pharmaceutical Co can be seen below:

2016-06-30 2016-07-31 2016-08-31 2016-09-30 2016-10-31 2016-11-30 2016-12-31 2017-01-31 2017-02-28 2017-03-31
Institutional Ownership 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.32
XPAE:BPC
87GF Score
Birzeit Pharmaceutical Co XPAE:BPC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Birzeit Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.32% mean?
Birzeit Pharmaceutical Co (XPAE:BPC) has a Institutional Ownership of 0.32% as of Jul. 24, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Birzeit Pharmaceutical Co and its competitors.
Is Birzeit Pharmaceutical Co's Institutional Ownership too high?
Birzeit Pharmaceutical Co's current Institutional Ownership is 0.32%. Overall, Birzeit Pharmaceutical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Birzeit Pharmaceutical Co's Institutional Ownership compare to ZTS and UTHR?
Birzeit Pharmaceutical Co's Institutional Ownership of 0.32% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Birzeit Pharmaceutical Co and its competitors. Birzeit Pharmaceutical Co's current Institutional Ownership is 0.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Birzeit Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Birzeit Pharmaceutical Co (XPAE:BPC) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.59, compared to a current price of $3.66 — trading 20.3% below its estimated fair value. The current Institutional Ownership is 0.32%. Birzeit Pharmaceutical Co's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Birzeit Pharmaceutical Co (XPAE:BPC), the current Institutional Ownership is 0.32% as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Birzeit Pharmaceutical Co (XPAE:BPC) Overvalued in 2026?

Based on GuruFocus' analysis, Birzeit Pharmaceutical Co stock appears to be undervalued. The current stock price of $3.66 is trading 20.3% below its estimated GF Value™ of $4.59. GuruFocus considers Birzeit Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for XPAE:BPC:

  • Institutional Ownership: 0.32%
  • GF Value™: $4.59 vs. price of $3.66 (20.3% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the XPAE:BPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Birzeit Pharmaceutical Co Business Description

Address 20 Shatella Street, Betunia Industrial Area, Ramallah, PSE
Birzeit Pharmaceutical Co operates as a pharmaceutical manufacturer in Palestine, producing a range of approximately 270 products across various production lines at four locations. Its portfolio comprises brands spanning multiple therapeutic areas. In addition to manufacturing, the company supplies its products to the local market through pharmacies and medical professionals.
87GF Score

Get the complete analysis for XPAE:BPC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.66
Price
$4.59
GF Value